Cytek BioSciences Inc
CTKB - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$796.8M
Close$
$0.21
96.3% downside
Current Fair Value
96.3% downsideOvervalued by 96.3% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $796.80 Million |
|---|---|
| Enterprise Value | $778.62 Million |
| Earnings per Share | $-0.52 |
| Beta | 1.16 |
| Outstanding Shares | 129,460,518 |
Return
| Return on Equity | -25.03% |
|---|---|
| Return on Assets | -18.03% |
| Return on Invested Capital | -11.67% |
Valuation & Multiples
| P/E Ratio | -9.84 |
|---|---|
| PEG | -8.36 |
| Price to Sales | 5.77 |
| Price to Book Ratio | 2.89 |
| Enterprise Value to Revenue | 3.77 |
| Enterprise Value to EBIT | -18.4 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$-0.09
Consensus analyst estimateRevenue Estimate
$47.31 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$-0.08
Consensus analyst estimateRevenue Estimate
$53.05 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.15%▼ 63.69% |
|---|---|
| Total Invested | $1.01M▼ 99.72% |
| Investors Holding | 25▼ 131.00% |
About Cytek BioSciences Inc
2,021 employees
